Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage

J Chem Neuroanat. 2005 Mar;29(2):113-26. doi: 10.1016/j.jchemneu.2004.10.001.

Abstract

The level of heme oxygenase-1 (HO-1) in the normal striatum is below the limit of immunodetection. However, HO-1 is overexpressed in both neural and non-neural cells in response to a wide range of lesions. We induced different types of lesions affecting the striatal cells or the main striatal afferent systems in rats to investigate if overexpression of HO-1 could be a useful histochemical marker of striatal damage. Thirty-six hours after intrastriatal or intraventricular injection of excitotoxins that affect striatal neurons (ibotenic acid) or of neurotoxins that affect striatal dopaminergic (6-hydroxydopamine) or serotonergic (5,7-dihydroxytriptamine) afferent terminals, or after surgical lesioning of cortico-striatal projections, there was intense induction of striatal HO-1 immunoreactivity (HO-1-ir). Double immunolabeling revealed that the HO-1-ir was located in glial cells. After intrastriatal injection of ibotenic acid, a central zone of neuronal degeneration contained numerous round and pseudopodic HO-1-ir cells, and was surrounded by a ring of HO-1-ir cells, most of which were immunoreactive for astroglial markers. Intraventricular injection of neurotoxins induced astroglial HO-1-ir cells which were more evenly distributed throughout the lesioned or denervated areas. HO-1-ir microglial cells were also observed in areas subjected to mechanical damage. The HO-1-ir was markedly lower or absent 1 week after lesion, and even more so 3 weeks after, although some HO-1-ir cells were still observed after intrastriatal injection of ibotenic acid or surgical corticostriatal deafferentation. The results indicate that determination of glial HO-1-ir is a useful histochemical marker for early stages of striatal damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,7-Dihydroxytryptamine
  • Afferent Pathways / injuries
  • Afferent Pathways / surgery
  • Animals
  • Astrocytes / enzymology
  • Basal Ganglia Diseases / enzymology*
  • Basal Ganglia Diseases / pathology
  • Basal Ganglia Diseases / physiopathology
  • Biomarkers
  • Corpus Striatum / enzymology*
  • Corpus Striatum / pathology
  • Corpus Striatum / physiopathology
  • Denervation
  • Dopamine / metabolism
  • Female
  • Gliosis / diagnosis
  • Gliosis / enzymology
  • Gliosis / pathology
  • Heat-Shock Proteins / biosynthesis*
  • Heme Oxygenase (Decyclizing)
  • Ibotenic Acid
  • Immunohistochemistry
  • Microglia / enzymology
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / enzymology*
  • Nerve Degeneration / physiopathology
  • Neuroglia / enzymology*
  • Neuroglia / pathology
  • Neurotoxins
  • Oxidopamine
  • Oxygenases / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / metabolism

Substances

  • Biomarkers
  • Heat-Shock Proteins
  • Neurotoxins
  • Ibotenic Acid
  • 5,7-Dihydroxytryptamine
  • Serotonin
  • Oxidopamine
  • Oxygenases
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
  • Dopamine